MediciNova Inc.
MNOV | NASDAQ
$3.02
-$0.28 (-8.48%)
Sep 22, 2026, 1:24 PM ET · Market open
Market Data
Market Cap $162.43M
Enterprise Value $-25.14B
Beta 0.63
Average Volume 43.51K
Shares Outstanding (Diluted) 49.22M
Shares Change YoY 0.36%
Institutional Ownership 10.98%
Exchange NASDAQ
ISIN US58468P2065
Price Performance
Price Change 1M 137.4%
Price Change 3M 142.7%
Price Change 6M 126.0%
Price Change YTD 148.1%
Price Change 1Y 157.8%
Price Change 3Y 57.9%
Price Change 5Y -15.4%
1M CAGR (ann.) 146.3%
1Y CAGR (ann.) 166.1%
5Y CAGR (ann.) -4.4%
All-Time CAGR -5.9%
Valuation
PE Ratio -15.00
Forward PE N/A
PEG Ratio -1.75
Forward PEG -0.20
PS Ratio 0.35
Forward PS 324.90
PB Ratio 0.00
P/FCF Ratio -0.03
P/Adj. FCF Ratio -0.03
P/OCF Ratio -0.08
EV/Sales -54.78
EV/EBIT 2,980.75
EV/EBITDA 2,978.24
EV/FCF 4.65
Earnings Yield -6.7%
FCF Yield -3327.5%
Adj. FCF Yield -3687.5%
Financial Health
Net Cash $25.3B
Total Debt $117.04M
Cash & Short-Term Investments $25.42B
Total Assets $40.43B
Current Ratio 8.75
Quick Ratio 8.75
Debt / Equity Ratio 0.00
Debt / EBITDA -13.87
Debt / FCF -0.02
OCF / Debt -46.09
Interest Coverage 0.00
Altman Z-Score -15.32
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 42.4%
Operating Profit Margin -2.0%
EBITDA Margin -1192.5%
Net Profit Margin -1168.2%
FCF Margin -1177.8%
Adj. FCF Margin -1305.2%
SBC / Revenue 19284.8%
SBC Impact (per share) -10.8%
Returns
Return on Assets -26.6%
Return on Equity -26.5%
Return on Invested Capital -31.5%
Return on Capital Employed -31.6%
Return on Tangible Assets -41.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 149.3%
Revenue CAGR 5Y 158.2%
Revenue CAGR 10Y 54.0%
EPS CAGR 3Y -11.9%
EPS CAGR 5Y 4.8%
EPS CAGR 10Y 5.4%
FCF CAGR 3Y -149.3%
FCF CAGR 5Y -98.9%
FCF CAGR 10Y -53.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 190.9%
Revenue Growth Next 3Y -35.0%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.06
EPS Growth Est (next Q) 0.0%
Revenue Est (next Q) $50K
Revenue Growth Est (next Q) -18.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6
Price Target Upside 81.8%
Cash Flow
Operating Cash Flow $-5.39B
Free Cash Flow $-5.4B
Adj. Free Cash Flow $-5.99B
FCF Per Share -$39.15
OCF Per Share -$39.15
OCF/S Ratio -209373.1%
Income Statement
Revenue $458.9M
Gross Profit $72.43K
Operating Income $-9.31M
EBITDA $-8.44M
Net Income $-2.32B
EPS (Diluted) -$0.22
Revenue / Employee $76.48M
Profit / Employee $-387.1M
Employees 6
Add to Watchlist
Select watchlists to add or remove MNOV